Search:

< Go Back

Rx Safes, Inc. Announces New War On Drugs
4 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner
Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA
Critical Process Filtration, Inc. Announces Expanded Technical Services and Validation Support
GenSpera Media Advisory; "Targeting thapsigargin towards tumors" Published in Steroids
Celsion to Present at the Rodman & Renshaw 16th Annual Healthcare Conference
The Leukemia & Lymphoma Society Provides Equity Financing to OncoPep to Support Clinical Trial for Myeloma Vaccine
CAIDE Looks into the Future: New App from Merz Pharmaceuticals Assesses the Risk of Getting Dementia Within the Next 20 Years
EnteroMedics Announces Three Year Diabetes, Hypertension and Weight Loss Data from the Maestro® RC System DM2 ENABLE Study
Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-APOCIII Rx in Patients with FCS
Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile
New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications
Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting
China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results
TWi Pharmaceuticals Receives US FDA Final Approval on Generic Megestrol Acetate 125mg/ml Oral Suspension
Co-development Terms & Agreements in Pharma, Biotech and Diagnostics
Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics
Pivotal Therapeutics Announces Second Quarter Financial Results
DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference
Surveyed Physicians Expect to Choose Between Future Biosimilars Based on Robustness and Number of Clinical Trials
Dental Equipment Market Worth $7,138.9 Million by 2019
ISPE Releases First Look at its Plan to Prevent Drug Shortages
Sihuan Pharmaceutical Announces 2014 Interim Results
Drug Represents First Potential Treatment for Common Anemia
Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting
Amerigen Pharmaceuticals Limited and the Ningbo Menovo Pharmaceutical Co., Ltd, today announced they had entered into a collaboration agreement regarding the development of generic pharmaceuticals, primarily targeting the United States market
FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure
Columbia Laboratories to participate in the Rodman & Renshaw 16th Annual Global Investment Conference
CVS Caremark Announces New Clinical Affiliation with MedStar Health
BioDelivery Sciences to Host Investor and Analyst Event and Webcast Friday, September 5 on BUNAVAIL™ Launch and Pipeline
Biostar Pharmaceuticals Inc. Engaged Chief Scientist Professor Xiaohui Zheng To Preside Over The Company's Product Development Projects
Ambit Announces Participation At Baird 2014 Health Care Conference
Fatty Liver Disease Therapeutics Clinical Trials Market Review 2014 Analysis Report Available at MarketOptimizer.org
TNI BioTech Inc. Announces First Shipment of Lodonal® to The Republic of Panama and The Republic of Malawi
AcelRx Pharmaceuticals to Participate in Two Upcoming Investor Events
Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury
Sinovac Announces Results of 2014 Annual General Meeting of Shareholders
Auxilium Pharmaceuticals, Inc. To Present At The Morgan Stanley Healthcare Conference
AccentHealth® Releases OTC White Paper Highlighting Physician's Active Role in OTC Recommendations and Purchasing Decisions
Actavis to Present at Morgan Stanley Global Healthcare Conference 2014
BioMed Realty Signs New Lease With GlycoMimetics At Its Newly Redeveloped Center For Life Science | Shady Grove Campus In Rockville, Maryland
GSK receives FDA approval of an additional Promacta® (eltrombopag) indication for use in patients with severe aplastic anaemia (SAA) who have had an insufficient response to immunosuppressive therapy (IST)
PRA Health Sciences Expands in Pennsylvania
Global Intranasal Drug Delivery Market 2014-2018: Key Vendors are Becton, Dickinson and Company, GlaxoSmithKline, Johnson & Johnson and Novartis
Global Cytomegalovirus Retinitis Market 2014-2018: Key Vendors are F. Hoffmann-La Roche, Gilead Sciences, Hospira and Shire
Biomedical Research Laboratories Named to Inc. 500 List of America's Fastest-Growing Companies
Synageva BioPharma™ To Present At The Baird 2014 Healthcare Conference
2015 Platinum Plans Are Best Buy for Consumers Using Expensive Specialty Drugs
Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder
New type 2 diabetes treatment Jardiance® (empagliflozin) tablets for adults now available in U.S. pharmacies

< Prev Next >
PR Newswire - United Business Media